Skip to Main Content

Advertisement

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 133, Issue 20

May 16 2019

In this Issue

EDITORIAL
BLOOD COMMENTARIES
PLENARY PAPER
REVIEW SERIES
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
TRANSPLANTATION
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Table of Contents

EDITORIAL

Introduction to a review series on human neutrophils

Nancy Berliner,Thomas D. Coates

View Articletitled, Introduction to a review series on human neutrophils

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS

To treat or not to treat, that is the NLPHL question
Clinical Trials & Observations

Joseph M. Connors

View Articletitled, To treat or not to treat, that is the NLPHL question

IMMUNOBIOLOGY AND IMMUNOTHERAPY

CAR-T–cell neurotoxicity: hope is on the horizon

Omar Ahmed

View Articletitled, CAR-T–cell neurotoxicity: hope is on the horizon

Lymphoid Neoplasia

HAP1 loss in l-asparaginase resistance

Maristella Maggi,Claudia Scotti

View Articletitled, HAP1 loss in <span class="small-caps">l</span>-asparaginase resistance

TRANSPLANTATION

Stem cell transplant in MF: it’s time to personalize

Francesco Passamonti

View Articletitled, Stem cell transplant in MF: it’s time to personalize

PLENARY PAPER

CLINICAL TRIALS AND OBSERVATIONS

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Clinical Trials & Observations

Sven Borchmann,Erel Joffe,Craig H. Moskowitz,Andrew D. Zelenetz,Ariela Noy,Carol S. Portlock,John F. Gerecitano,Connie L. Batlevi,Philip C. Caron,Pamela Drullinsky,Audrey Hamilton,Paul A. Hamlin, Jr,Steven M. Horwitz,Anita Kumar,Matthew J. Matasar,Alison J. Moskowitz,Colette N. Owens,M. Lia Palomba,Anas Younes,David J. Straus

View Articletitled, Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

Supplemental data

REVIEW SERIES

Inflammatory consequences of inherited disorders affecting neutrophil function

Mary C. Dinauer

View Articletitled, Inflammatory consequences of inherited disorders affecting neutrophil function

Neutrophils as regulators of the hematopoietic niche

Itziar Cossío,Daniel Lucas,Andrés Hidalgo

View Articletitled, Neutrophils as regulators of the hematopoietic niche

Neutrophil transendothelial migration: updates and new perspectives

Marie-Dominique Filippi

View Articletitled, Neutrophil transendothelial migration: updates and new perspectives

Neutrophil plasticity in the tumor microenvironment

Morgan A. Giese,Laurel E. Hind,Anna Huttenlocher

View Articletitled, Neutrophil plasticity in the tumor microenvironment

Cross talk between neutrophils and the microbiota

Dachuan Zhang,Paul S. Frenette

View Articletitled, Cross talk between neutrophils and the microbiota

Neutrophils and NETs in modulating acute and chronic inflammation

Fernanda V. S. Castanheira,Paul Kubes

View Articletitled, Neutrophils and NETs in modulating acute and chronic inflammation

Neutrophils: back in the thrombosis spotlight

Denis F. Noubouossie,Brandi N. Reeves,Brian D. Strahl,Nigel S. Key

View Articletitled, Neutrophils: back in the thrombosis spotlight

HEMATOPOIESIS AND STEM CELLS

A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency

Kerstin B. Kaufmann,Laura Garcia-Prat,Qiang Liu,Stanley W. K. Ng,Shin-Ichiro Takayanagi,Amanda Mitchell,Erno Wienholds,Peter van Galen,Christian A. Cumbaa,Mike J. Tsay,Chiara Pastrello,Elvin Wagenblast,Gabriela Krivdova,Mark D. Minden,Eric R. Lechman,Sasan Zandi,Igor Jurisica,Jean C. Y. Wang,Stephanie Z. Xie,John E. Dick

View Articletitled, A stemness screen reveals <em>C3orf54/INKA1</em> as a promoter of human leukemia stem cell latency

Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
Clinical Trials & Observations

Philipp Karschnia,Justin T. Jordan,Deborah A. Forst,Isabel C. Arrillaga-Romany,Tracy T. Batchelor,Joachim M. Baehring,Nathan F. Clement,L. Nicolas Gonzalez Castro,Aline Herlopian,Marcela V. Maus,Michaela H. Schwaiblmair,Jacob D. Soumerai,Ronald W. Takvorian,Ephraim P. Hochberg,Jeffrey A. Barnes,Jeremy S. Abramson,Matthew J. Frigault,Jorg Dietrich

There is a Blood Commentary on this article in this issue.

View Articletitled, Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

LYMPHOID NEOPLASIA

HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway
CME

Jung Kwon Lee,SungMyung Kang,Xidi Wang,Jesusa L. Rosales,Xu Gao,Hee-Guk Byun,Yan Jin,Songbin Fu,Jinghua Wang,Ki-Young Lee

View Articletitled, HAP1 loss confers <span class="small-caps">l</span>-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway

Supplemental data

TRANSPLANTATION

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Nico Gagelmann,Markus Ditschkowski,Rashit Bogdanov,Swann Bredin,Marie Robin,Bruno Cassinat,Rabia Shahswar,Felicitas Thol,Michael Heuser,Gerard Socié,Dietrich Beelen,Ioanna Triviai,Anita Badbaran,Nicolaus Kröger

There is a Blood Commentary on this article in this issue.

View Articletitled, Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Supplemental data

BLOOD WORK

Mast cell leukemia and hemophagocytosis in a patient with myelodysplastic syndrome

Jay Yang,Ali Gabali

View Articletitled, Mast cell leukemia and hemophagocytosis in a patient with myelodysplastic syndrome

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

l-Asparaginase resistance genes in ALL
CME

View Articletitled, <span class="small-caps">l</span>-Asparaginase resistance genes in ALL

Cover Image

Cover Image

Confocal image of human acute myeloid leukemia 8227 CD34⁺ CD38⁺ cells overexpressing the PAK4 inhibitor C3orf54/INKA1. INKA1 regulates G₀ exit of leukemia stem cells by interfering with nuclear localization of PAK4 (red), with concomitant reduction of H4K16ac (green) and CDK6 (yellow; blue: DAPI [4',6-diamidino-2-phenylindole]) levels. See the article by Kaufmann et al on page 2198.
Front Matter
Table of Contents
Back Matter
Editorial Board

Advertisement

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Relating NF-κB regulation to MPN pathogenesis

The elusive endothelial iron transporter

AAV delivers as a lingering guest, not an invader

PCM1::JAK2 myeloproliferative neoplasm suggested by bone marrow histopathological features

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Advertisement

Advertisement

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement